Cargando…

Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization

In this study we indicated that impaired serological responses to SARS‐CoV‐2 infection among patients with IBD, could have significant implications for this group of patients and should be considered in vaccination program.[Image: see text]

Detalles Bibliográficos
Autores principales:	Ghavami, Shaghayegh Baradaran, Shahrokh, Shabnam, Asadzadeh Aghdaei, Hamid, Khoramjoo, Seyed Mobin, Farmani, Maryam, Kazemifard, Nesa, Parigi, Tommaso Lorenzo, Danese, Silivio, Balaii, Hedieh, Sherkat, Ghazal, Ebrahimi Daryani, Nasser, Alborzi, Foroogh, Vossoughinia, Hassan, Zali, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021711/ https://www.ncbi.nlm.nih.gov/pubmed/35475199 http://dx.doi.org/10.1002/jgh3.12725

Ejemplares similares

Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
por: Khoramjoo, Seyed Mobin, et al.
Publicado: (2022)

Association between variants of the autophagy related gene ATG16L1 in inflammatory bowel diseases and clinical statues
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2019)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2022)

Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2021)

Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitis
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2023)

Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy
por: Kazemifard, Nesa, et al.
Publicado: (2022)

The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
por: Olfatifar, Meysam, et al.
Publicado: (2021)

Apoptosis markers of circulating leukocytes are associated with the clinical course of inflammatory bowel disease
por: Amini Kadijani, Azade, et al.
Publicado: (2018)

Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality of Life in Patients with Ulcerative Colitis
por: Shahrokh, Shabnam, et al.
Publicado: (2021)

Evaluation of IL-17B and IL-17F mRNA expression in peripheral blood mononuclear cells and association with clinical outcome of IBD patients
por: Safari, Mohammad Taghi, et al.
Publicado: (2017)

Detection of SARS-CoV-2 Genome in Stool and Plasma Samples of Laboratory Confirmed Iranian COVID-19 Patients
por: Makhmalbaf, Mobin, et al.
Publicado: (2022)

Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Detailed analysis of total colectomy on health-related quality of life in adult patients with ulcerative colitis
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2017)

IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Translation and cross-cultural adaptation of the Persian version of inflammatory bowel disease-fatigue (IBD-F) self-assessment questionnaire
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2023)

Time trend analysis and demographic features of inflammatory bowel disease in Tehran
por: Balaii, Hedieh, et al.
Publicado: (2015)

Toll-Like Receptor 7 a Novel Non-Invasive Inflammatory Genetic Sensor for Ulcerative Colitis Remission Monitoring
por: Asadzadeh-Aghdaei, Hamid, et al.
Publicado: (2023)

Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches
por: Olfatifar, Meysam, et al.
Publicado: (2021)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

Association between TNF-α rs1799964 and RAF1 rs1051208 MicroRNA binding site SNP and gastric cancer susceptibility in an Iranian population
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2017)

Small Intestine Perforation in a 69-Year-Old Man with COVID-19
por: Miroliaee, Arash, et al.
Publicado: (2022)

Expression of Toll-Like Receptors 2, 4 and 5 in Relation to Gut Microbiota in Colon Neoplasm Patients with and without Inflammatory Bowel Disease
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2022)

Determining the degree of adherence to treatment in inflammatory bowel disease patients
por: Balaii, Hedieh, et al.
Publicado: (2018)

High Prevalence Rate of Microbial Contamination in Patient-Ready Gastrointestinal Endoscopes in Tehran, Iran: an Alarming Sign for the Occurrence of Severe Outbreaks
por: Houri, Hamidreza, et al.
Publicado: (2022)

Erratum for Houri et al., “High Prevalence Rate of Microbial Contamination in Patient-Ready Gastrointestinal Endoscopes in Tehran, Iran: an Alarming Sign for the Occurrence of Severe Outbreaks”
por: Houri, Hamidreza, et al.
Publicado: (2023)

Estimation the direct cost of inflammatory bowel disease in Iranian patients; the one- year follow-up
por: Balaii, Hedieh, et al.
Publicado: (2019)

Retroperitoneal lymphangioma as the final diagnosis of a middle-aged woman with abdominal pain: a case report
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2023)

Association between two single base polymorphisms of intercellular adhesion molecule 1 gene and inflammatory bowel disease
por: Habibi, Manijeh, et al.
Publicado: (2016)

The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study
por: Azramezani Kopi, Tayebeh, et al.
Publicado: (2019)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2
por: Mirjalali, Hamed, et al.
Publicado: (2020)

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes
por: Alebouyeh, Masoud, et al.
Publicado: (2015)

Effect of Selenium Supplementation on Expression of SIRT1 and PGC-1α Genes in Ulcerative Colitis Patients: a Double Blind Randomized Clinical Trial
por: Khazdouz, Maryam, et al.
Publicado: (2020)

Sequence variations of Epstein–Barr virus LMP1 gene in gastric cancer and chronic gastritis isolates from Iranian patients
por: Sarshari, Behrang, et al.
Publicado: (2022)

Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

Effect of vitamin D3 supplementation on TNF-α serum level and disease activity index in Iranian IBD patients
por: Dadaei, Tahereh, et al.
Publicado: (2015)

Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model
por: Abdolahi, Shahrokh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_036daamub55tq55kk4n8fjq413